Weichang Zhou, PhD WuXi Biologics

Dr. Weichang Zhou is a  well-recognized technical and managerial leader with 25+ years of broad industrial experience and demonstrated accomplishments in biologics (recombinant proteins, monoclonal antibodies and viral vaccines) manufacturing process development, scale-up, characterization, technology transfer, manufacturing and regulatory support.  He has been providing scientific excellence and strategic leaderships to many multifunctional CMC teams by serving as senior executive leadership positions as Chief Technology Officer and Senior Vice President, Biologics Development and Manufacturing at WuXi Biologics and WuXi AppTec, Senior Director of Commercial Cell Culture Development at Genzyme, a SANOFI Company, Senior Director of Process Sciences and Engineering at PDL BioPharma and Associate Director of Fermentation and Cell Culture at Merck.

Dr. Zhou has published over 50 scientific papers and hold four patents. He has delivered over 100 presentations and lectures in international conferences and professional courses. He has been organizing and chairing conferences and symposia on topics related to development and commercialization of bioprocesses and biologics. He served as one of two chairs for the Cell Culture Engineering (XIV) 2014 conference, Biochemical Engineering (XIII) 2003 conference and 2004 program of the Division of Biochemical Technology, American Chemical Society in the 227th ACS Spring National Meeting. He was elected as a fellow of the American Chemical Society in 2013 and a fellow of the American Institute for Medical and Biological Engineering (AIMBE) in 2002.  Dr. Zhou was an executive committee member of the Division of Biochemical Technology (BIOT), American Chemical Society between 2003 and 2014 having served as division’s Program Chair (2004), Awards Chair (2005-2008), Division's Chair-Elect (2008), Chair (2009) and Past-Chair (2010).